Frailty in ageing persons with multiple sclerosis.

Xavier AyrignacCatherine LarochelleMark KeezerElaine RogerJosée PoirierBoaz LahavMarc GirardAlexandre PratPierre Duquette

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2020)

Our results suggest that frailty can be routinely assessed in pwMS. Increased frailty in MS patients suggests that, along with MS therapeutics, a tailored multidisciplinary approach of ageing pwMS is needed.

Keyphrases

multiple sclerosis
end stage renal disease
mass spectrometry
community dwelling
ms ms
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
small molecule
white matter
quality improvement
patient reported outcomes